Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • NGSfan
    Senior Member
    • Apr 2009
    • 181

    #1

    Postdoctoral Position in Computational Biology on Cancer Biomarker Discovery

    A postdoctoral position in Computational Biology at Boehringer Ingelheim Oncology in Vienna is available immediately.

    Research topics:
    The successful candidate will mainly work in the area of cancer biomarker discovery with the aim to predict and understand genotype and transcriptome dependent differential responses to novel targeted therapies.
    This includes the utilization of genomics data delivered by next generation sequencing, expression arrays and SNP-chips. Chemo-sensitivity profiling screens across large cancer cell line panels will form the basis for the discovery of predictive response biomarkers. Furthermore, mechanism of action studies as well as the elucidation of drug induced resistance mechanisms are additional areas of interest.

    Requirements:
    The candidate should have a PhD degree in biology, bioinformatics, or in a related discipline with a proven record in genomics data analysis. A profound understanding of cancer biology and the ability to translate and communicate results is highly desired. The candidate should be comfortable in handling large datasets and be able to identify and implement computationally efficient data processing strategies in a linux environment.

    Terms and locale:
    The position is initially for two years, location Vienna, Austria.

    Institution Background:
    Boehringer Ingelheim is a research-driven international pharmaceutical company with over 40.000 employees world-wide. The research site in Vienna is solely dedicated to cancer drug discovery.

    Contact:
    Interested candidates should contact [email protected] along with copies of their CV, publication list and names of reference persons.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...